[Newly occurring loss of visual acuity in choroidal osteoma].
CONCLUSION: Monitoring is necessary even for primarily benign CO in order to detect secondary complications causing loss of visual acuity, e. g. secondary CNV. Anti-VEGF IVT represents an approved treatment option.
PMID: 28540579 [PubMed - as supplied by publisher]
Source: Der Ophthalmologe - Category: Opthalmology Authors: Schuh A, Foerster P, Priglinger S, Eibl-Lindner K Tags: Ophthalmologe Source Type: research